Provider review
Metabolyz review
Publishes the microdose ladder in milligrams and no price for any GLP-1.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
No GLP-1 price published at any tier
Visit MetabolyzIt is the reverse of the usual gap: the dose is knowable and the cost is not, while its peptide catalog is priced openly.
Price as published
Metabolyz
No GLP-1 price published at any tier
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Almost every provider here publishes a price and hides the dose. Metabolyz does the opposite — its microdose page carries an actual milligram ladder, which is rarer and arguably more useful, and then declines to price any GLP-1 product at all. Semaglutide, tirzepatide and the microdose each say only that they are available by consultation, while the separate peptide catalog on the same site carries per-molecule figures. So the site can publish a price and chooses not to on the products it leads with. Unreplaced template placeholder text ships on the treatment pages in production.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see the intended microdose ladder in milligrams before you talk to anyone
- You want lifestyle coaching positioned as a named part of the program rather than an add-on
- You are comfortable starting an eligibility quiz without any price in hand
Look elsewhere if
- You want any GLP-1 price at all before starting — none is published at any tier
- You want a finished site: placeholder template text ships on the treatment pages
- You want a named pharmacy, a compounding designation, or a list of states served
What it actually costs
Price as published
No GLP-1 price published at any tier
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
78 of the 548 programs here price a small dose this way. Publishes no price for any GLP-1 product — all three treatment pages say only that they are available by consultation — while its separate peptide catalog does carry per-molecule figures. Its microdose page does publish an intended dose ladder in milligrams, the reverse of the usual gap: you can know the dose but not the price.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Included
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- The microdose page publishes an actual dose ladder in milligrams — 0.10 mg, 0.15 mg and 0.25 mg — which almost nothing else here does for a microdose protocol
- The peptide catalog carries real per-molecule from-prices organized by clinical goal, so the site is capable of publishing a price when it wants to
- The terms of use are unusually direct that the operator is a technology platform and not a healthcare provider
- Positions coaching in nutrition, movement and lifestyle as a named pillar alongside medication, with structured check-ins described
- Runs separate eligibility funnels for GLP-1 and for peptides, so the two catalogs are not conflated
- The legal entity is named plainly in the terms of use
Pharmacy, labs and oversight
Metabolyz does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Metabolyz publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Metabolyz is operated by a company that states in its terms that it owns the site and acts solely as a technology platform, explicitly disclaiming that it practices medicine, provides clinical care, or prepares or dispenses medications. It sells semaglutide, tirzepatide and a GLP-1 Microdose protocol, plus a separate peptide catalog with its own eligibility quiz. The pitch is GLP-1 therapy paired with lifestyle coaching in nutrition and movement rather than medication alone. No pharmacy is named, no compounding designation is stated, and no list of states served is published.
The honest cons
Publishes no price for any GLP-1 product at any tier — semaglutide, tirzepatide and the microdose all say only "available by consultation" — while the peptide catalog on the same site carries per-molecule prices. It can publish a price and chooses not to on the products it leads with
- Unreplaced template placeholder text ships in production on the GLP-1 treatment pages
- The site is a near-identical template sibling of another brand here — the same application bundle, the same treatment data structure, the same taglines — under a different operating company, and neither brand discloses the relationship
- A microdose price is built into the page but never shown, so the number exists and is withheld from the reader
- No pharmacy named, no 503A/503B designation, and no list of states served anywhere on the site
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Metabolyz is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Metabolyz does. Both are partners: we may earn a commission if you start care through these links.
Partner
HumeCare+
$199–$299/mo (gated)
No low-dose price published
Partner
Wellorithm
Compounded line not published · brand pens priced
No low-dose price published
Where this sits
#66 of 548
Ordered with the companies that pay us first, and Metabolyz is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Microdosing semaglutide
- Microdose & reconstitution calculator
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Oak
$250–$300/mo
- Vs median
- $75/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Oak review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.